Variant report
Variant | esv3330614 |
---|---|
Chromosome Location | chr1:160953378-160955501 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:160952049..160953710-chr1:160957202..160960136,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs114480413 | chr1:160953380-160953381 | Weak transcription Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs548539881 | chr1:160953449-160953450 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
3 | rs549954860 | chr1:160953493-160953494 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
4 | rs534697738 | chr1:160953516-160953517 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
5 | rs73015878 | chr1:160953523-160953524 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
6 | rs59471747 | chr1:160953538-160953539 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
7 | rs397963074 | chr1:160953551-160953552 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
8 | rs61803662 | chr1:160953553-160953554 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
9 | rs190839351 | chr1:160953597-160953598 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
10 | rs2988723 | chr1:160953668-160953669 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs557310577 | chr1:160953736-160953737 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs573958114 | chr1:160953827-160953828 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs182324770 | chr1:160953853-160953854 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553387582 | chr1:160953866-160953867 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs573298463 | chr1:160953872-160953873 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545483005 | chr1:160953880-160953881 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs377018085 | chr1:160953891-160953892 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs370871010 | chr1:160953893-160953894 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534452496 | chr1:160953904-160953905 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs386636084 | chr1:160953905-160953906 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs544445202 | chr1:160953909-160953910 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs145337879 | chr1:160953953-160953954 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs114614805 | chr1:160953967-160953968 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs113025104 | chr1:160953995-160953996 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs548600545 | chr1:160954042-160954043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs147679381 | chr1:160954054-160954055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs535783599 | chr1:160954066-160954067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs553430028 | chr1:160954098-160954099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs3007153 | chr1:160954108-160954109 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
30 | rs573437486 | chr1:160954117-160954118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs368662924 | chr1:160954127-160954128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs7542720 | chr1:160954132-160954133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs12123794 | chr1:160954141-160954142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs12123795 | chr1:160954144-160954145 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
35 | rs74579080 | chr1:160954151-160954152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs12122969 | chr1:160954152-160954153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs12122970 | chr1:160954157-160954158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs71090346 | chr1:160954160-160954161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs71517285 | chr1:160954166-160954167 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs71517286 | chr1:160954169-160954170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs12123749 | chr1:160954177-160954178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs12124542 | chr1:160954178-160954179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs71090347 | chr1:160954184-160954185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs7540301 | chr1:160954195-160954196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs7542731 | chr1:160954196-160954197 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs377721941 | chr1:160954204-160954205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs371392777 | chr1:160954205-160954206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs375584967 | chr1:160954209-160954210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs571222841 | chr1:160954212-160954213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs71517287 | chr1:160954221-160954222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 17899364 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Type 2 diabetes | 19141583 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Systemic lupus erythematosus | 19220326 | CNVD |
Systemic lupus erythematosus | 19287148 | CNVD |
Glomerulonephritis | 19341492 | CNVD |
Systemic lupus erythematosus | 18559452 | CNVD |
Systemic autoimmune disease | 17597778 | CNVD |
Glomerulonephritis | 17008540 | CNVD |
Glomerulonephritis | 16482158 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
Breast cancer | 21045282 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 20409316 | CNVD |
Mental retardation | 17847001 | CNVD |
Idiopathic thrombocytopenic purpura | 17827395 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:160943200-160959800 | Weak transcription | Pancreas | Pancrea |
2 | chr1:160948600-160968000 | Weak transcription | Ovary | ovary |
3 | chr1:160952200-160953800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr1:160952200-160956400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr1:160952200-160964400 | Weak transcription | Placenta Amnion | Placenta Amnion |
6 | chr1:160952200-160967000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr1:160952400-160954000 | Enhancers | H1 Cell Line | embryonic stem cell |
8 | chr1:160952400-160954000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr1:160952400-160956400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
10 | chr1:160952400-160957200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
11 | chr1:160953000-160953600 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr1:160953000-160953600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
13 | chr1:160953000-160953800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
14 | chr1:160953200-160953400 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
15 | chr1:160953200-160953600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
16 | chr1:160953200-160966600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
17 | chr1:160953400-160953600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
18 | chr1:160953600-160955600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
19 | chr1:160953600-160955800 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
20 | chr1:160953600-160956200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
21 | chr1:160953800-160968200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
22 | chr1:160954000-160956000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
23 | chr1:160954000-160956600 | Weak transcription | H1 Cell Line | embryonic stem cell |
24 | chr1:160954200-160959800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
25 | chr1:160955400-160956000 | ZNF genes & repeats | HUES64 Cell Line | embryonic stem cell |